| Abstrakt: |
A recent report in Heart Disease Weekly discusses the use of drug-coated balloons in coronary angioplasty as an alternative to drug-eluting stents. The study highlights the efficacy of drug-coated balloons in inhibiting intimal hyperplasia and their application in various clinical contexts such as de novo lesions, small vessel disease, and acute coronary syndromes. The research aims to provide a comprehensive review of drug-coated balloon platforms, their applications, supporting studies, and future perspectives in the field of interventional cardiology. [Extracted from the article] |
